DEREK TOWERY: Open Payments
NPI 1346237351 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 64 payments from 13 companies in 2025. Trend: 2023 $1,542 · 2024 $1,501 · 2025 $1,509
Food & beverage: $1,409Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $452 |
| Janssen Biotech, Inc. | 10 | $292 |
| GENZYME CORPORATION | 5 | $155 |
| UCB, Inc. | 7 | $136 |
| Novartis Pharmaceuticals Corporation | 6 | $107 |
| Lilly USA, LLC | 5 | $88 |
| LEO Pharma Inc. | 4 | $80 |
| Organogenesis Inc. | 2 | $68 |
| PFIZER INC. | 3 | $46 |
| Amgen Inc. | 1 | $23 |
Products named: RINVOQ, TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, TALTZ, ADBRY, COSENTYX.
Industry payments across MO — which companies pay providers there.
